- Home
- HOOK vs LGCB Comparison
HOOK vs LGCB Comparison
Compare HOOK & LGCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOOK
- LGCB
- Stock Information
- Founded
- HOOK 2011
- LGCB 2011
- Country
- HOOK United States
- LGCB Japan
- Employees
- HOOK N/A
- LGCB N/A
- Industry
- HOOK Biotechnology: Pharmaceutical Preparations
- LGCB
- Sector
- HOOK Health Care
- LGCB
- Exchange
- HOOK Nasdaq
- LGCB Nasdaq
- Market Cap
- HOOK 15.3M
- LGCB 14.8M
- IPO Year
- HOOK 2019
- LGCB 2023
- Fundamental
- Price
- HOOK $1.20
- LGCB $2.40
- Analyst Decision
- HOOK Buy
- LGCB
- Analyst Count
- HOOK 4
- LGCB 0
- Target Price
- HOOK $10.67
- LGCB N/A
- AVG Volume (30 Days)
- HOOK 65.1K
- LGCB 7.8K
- Earning Date
- HOOK 08-07-2025
- LGCB 07-03-2025
- Dividend Yield
- HOOK N/A
- LGCB N/A
- EPS Growth
- HOOK N/A
- LGCB N/A
- EPS
- HOOK N/A
- LGCB N/A
- Revenue
- HOOK $9,351,000.00
- LGCB $10,289,681.00
- Revenue This Year
- HOOK N/A
- LGCB N/A
- Revenue Next Year
- HOOK N/A
- LGCB N/A
- P/E Ratio
- HOOK N/A
- LGCB N/A
- Revenue Growth
- HOOK N/A
- LGCB N/A
- 52 Week Low
- HOOK $0.72
- LGCB $1.22
- 52 Week High
- HOOK $6.77
- LGCB $57.05
- Technical
- Relative Strength Index (RSI)
- HOOK 39.18
- LGCB 56.82
- Support Level
- HOOK $1.13
- LGCB $2.25
- Resistance Level
- HOOK $1.35
- LGCB $2.54
- Average True Range (ATR)
- HOOK 0.06
- LGCB 0.13
- MACD
- HOOK -0.01
- LGCB 0.01
- Stochastic Oscillator
- HOOK 40.64
- LGCB 74.29
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.
About LGCB Linkage Global Inc
Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.